Brief: Ultimovacs In Collaboration With Big Pharma Company And European Oncology Clinical Trial Group

Zelluna ASA

27/05/2020 15:33

May 27 (Reuters) - Ultimovacs ASA  ULTIMO.OL :
    * ANNOUNCES COLLABORATION WITH BIG PHARMA COMPANY AND
LEADING
    * ENTERED INTO A COLLABORATION WITH A LEADING BIG PHARMA
COMPANY
AND A EUROPEAN ONCOLOGY CLINICAL TRIAL GROUP
    * SUBJECT TO FINAL AGREEMENT BETWEEN ULTIMOVACS, SPONSOR AND
BIG
PHARMA PARTNER, WHICH IS PLANNED TO BE SIGNED IN Q3 2020, FIRST
PATIENT IS EXPECTED TO BE ENROLLED IN STUDY DURING Q4 2020 WITH
READ-OUT OF PRIMARY ENDPOINTS ANTICIPATED DURING FIRST HALF OF
2023
    * TO EVALUATE UV1 IN A THIRD PHASE II CLINICAL TRIAL

Source text for Eikon:  ID:nObiS9W2za 
Further company coverage:  ULTIMO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))